FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319923074> ?p ?o ?g. }

• W4319923074 endingPage "3515" @default.
• W4319923074 startingPage "3515" @default.
• W4319923074 abstract "Activating mutations in KIT (CD117) have been associated with several diseases, including gastrointestinal stromal tumors and mastocytosis. Rapidly progressing pathologies or drug resistance highlight the need for alternative treatment strategies. Previously, we reported that the adaptor molecule SH3 binding protein 2 (SH3BP2 or 3BP2) regulates KIT expression at the transcriptional level and microphthalmia-associated transcription factor (MITF) expression at the post-transcriptional level in human mast cells and gastrointestinal stromal tumor (GIST) cell lines. Lately, we have found that the SH3BP2 pathway regulates MITF through miR-1246 and miR-5100 in GIST. In this study, miR-1246 and miR-5100 were validated by qPCR in the SH3BP2-silenced human mast cell leukemia cell line (HMC-1). MiRNA overexpression reduces MITF and MITF-dependent target expression in HMC-1. The same pattern was observed after MITF silencing. In addition, MITF inhibitor ML329 treatment reduces MITF expression and affects the viability and cell cycle progression in HMC-1. We also examine whether MITF downregulation affected IgE-dependent mast cell degranulation. MiRNA overexpression, MITF silencing, and ML329 treatment reduced IgE-dependent degranulation in LAD2- and CD34+-derived mast cells. These findings suggest MITF may be a potential therapeutic target for allergic reactions and deregulated KIT mast-cell-mediated disorders." @default.
• W4319923074 created "2023-02-11" @default.
• W4319923074 creator A5024990522 @default.
• W4319923074 creator A5029625997 @default.
• W4319923074 creator A5044137839 @default.
• W4319923074 creator A5055578258 @default.
• W4319923074 creator A5069484742 @default.
• W4319923074 creator A5071300125 @default.
• W4319923074 creator A5085053912 @default.
• W4319923074 date "2023-02-09" @default.
• W4319923074 modified "2023-10-06" @default.
• W4319923074 title "MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation" @default.
• W4319923074 cites W1493098692 @default.
• W4319923074 cites W1542443684 @default.
• W4319923074 cites W1635979695 @default.
• W4319923074 cites W1965448265 @default.
• W4319923074 cites W1965851933 @default.
• W4319923074 cites W1966467063 @default.
• W4319923074 cites W1970343716 @default.
• W4319923074 cites W1976696689 @default.
• W4319923074 cites W1986784635 @default.
• W4319923074 cites W1988407228 @default.
• W4319923074 cites W1988784360 @default.
• W4319923074 cites W1989656747 @default.
• W4319923074 cites W1992704301 @default.
• W4319923074 cites W1995063959 @default.
• W4319923074 cites W2000371206 @default.
• W4319923074 cites W2007742656 @default.
• W4319923074 cites W2013178885 @default.
• W4319923074 cites W2014989641 @default.
• W4319923074 cites W2015009944 @default.
• W4319923074 cites W2027370231 @default.
• W4319923074 cites W2051718122 @default.
• W4319923074 cites W2061941270 @default.
• W4319923074 cites W2062818637 @default.
• W4319923074 cites W2101117089 @default.
• W4319923074 cites W2102249865 @default.
• W4319923074 cites W2108167539 @default.
• W4319923074 cites W2108233183 @default.
• W4319923074 cites W2112370482 @default.
• W4319923074 cites W2114305100 @default.
• W4319923074 cites W2125842849 @default.
• W4319923074 cites W2134629862 @default.
• W4319923074 cites W2150755837 @default.
• W4319923074 cites W2152473626 @default.
• W4319923074 cites W2152764077 @default.
• W4319923074 cites W2171398108 @default.
• W4319923074 cites W2254460105 @default.
• W4319923074 cites W2463631172 @default.
• W4319923074 cites W2565342730 @default.
• W4319923074 cites W2567187028 @default.
• W4319923074 cites W2570204410 @default.
• W4319923074 cites W2594856347 @default.
• W4319923074 cites W261781676 @default.
• W4319923074 cites W269249036 @default.
• W4319923074 cites W2743027761 @default.
• W4319923074 cites W2743874938 @default.
• W4319923074 cites W2753355630 @default.
• W4319923074 cites W2768781242 @default.
• W4319923074 cites W2776905669 @default.
• W4319923074 cites W2790903418 @default.
• W4319923074 cites W2805777294 @default.
• W4319923074 cites W2891445983 @default.
• W4319923074 cites W2945954586 @default.
• W4319923074 cites W2973117278 @default.
• W4319923074 cites W2979988877 @default.
• W4319923074 cites W3005443271 @default.
• W4319923074 cites W3016358303 @default.
• W4319923074 cites W3045894212 @default.
• W4319923074 cites W3110500269 @default.
• W4319923074 cites W3116966237 @default.
• W4319923074 cites W3118341807 @default.
• W4319923074 cites W3169679792 @default.
• W4319923074 cites W4200317891 @default.
• W4319923074 cites W4210637396 @default.
• W4319923074 cites W4221053664 @default.
• W4319923074 cites W4237105267 @default.
• W4319923074 cites W4287582753 @default.
• W4319923074 cites W4306181015 @default.
• W4319923074 cites W4311613647 @default.
• W4319923074 doi "https://doi.org/10.3390/ijms24043515" @default.
• W4319923074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36834926" @default.
• W4319923074 hasPublicationYear "2023" @default.
• W4319923074 type Work @default.
• W4319923074 citedByCount "1" @default.
• W4319923074 countsByYear W43199230742023 @default.
• W4319923074 crossrefType "journal-article" @default.
• W4319923074 hasAuthorship W4319923074A5024990522 @default.
• W4319923074 hasAuthorship W4319923074A5029625997 @default.
• W4319923074 hasAuthorship W4319923074A5044137839 @default.
• W4319923074 hasAuthorship W4319923074A5055578258 @default.
• W4319923074 hasAuthorship W4319923074A5069484742 @default.
• W4319923074 hasAuthorship W4319923074A5071300125 @default.
• W4319923074 hasAuthorship W4319923074A5085053912 @default.
• W4319923074 hasBestOaLocation W43199230741 @default.
• W4319923074 hasConcept C104317684 @default.
• W4319923074 hasConcept C119056186 @default.
• W4319923074 hasConcept C127561419 @default.

• next